ZYUS Life Sciences Corporation (TSXV: ZYUS)
Health Care · Pharmaceuticals · CA
CA$0.58
-3.33% today · -14.3% 1Y
ZYUS Life Sciences Corporation (TSXV: ZYUS) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $33.89M.
Over the last twelve months the share price has lost 14.3%, trading between 0.37 and 0.75.
Tweenvest scores ZYUS Life Sciences Corporation across four factors: quality 20/100, value 62/100. Its strongest factor is value.
ZYUS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $33.89M
- Revenue (TTM)
- $263.36K
- P/E
- —
- EPS
- -0.25
- Dividend yield
- —
- Beta (5Y)
- 0.16
- 52-week high
- CA$0.75
- 52-week low
- CA$0.37
- Avg volume (3M)
- —
- Shares outstanding
- 80.52M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| SoftOx Solutions ASOB: SOFTX | $35.08M | Nkr0.13 | -3.24% |
| Vidipha Central Pharmaceutical Joint Stock CompanyHOSE: VDP | $34.74M | ₫40,850.00 | +21.22% |
| Botanix Pharmaceuticals LimitedASX: BOT | $34.24M | AU$0.02 | -10.00% |
| PRISM BioLab Co.,LTDTSE: 206A | $34.22M | ¥146.00 | -15.12% |
| Anxo Pharmaceutical Co., Ltd.TPEX: 6677 | $33.42M | NT$19.00 | -0.78% |
| Prince Pharmaceutical Co., Ltd.TPEX: 6935 | $33.41M | NT$28.45 | -0.18% |
| Medical Developments International LimitedASX: MVP | $33.28M | AU$0.43 | -4.49% |
| Navamedic ASAOB: NAVA | $33.13M | Nkr13.30 | -0.37% |
Figures last refreshed Oct 4, 2026.